Analysis of prognostic factors for esophageal squamous cell carcinoma withdistant organ metastasis at initial diagnosis

Journal of the Chinese Medical Association

Volumn 77, Issue 11, 2014, Pages 562-566

  Chen, Ming Qiu ^a   Xu, Ben Hua ^a   Zhang, Ying Ying ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal neoplasms; Neoplasm metastasis; Prognosis; Therapy

Indexed keywords

CAPECITABINE; CARMOFUR; CISPLATIN; FOLINATE CALCIUM; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; LOBAPLATIN; NEDAPLATIN; OXALIPLATIN; PACLITAXEL; TEGAFUR;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHINESE MEDICINE; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STOMACH FISTULA; SURVIVAL RATE; SURVIVAL TIME; ESOPHAGUS TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84922670463     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2014.05.014     Document Type: Article

References (17)

1. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-2150.
2. Bancewicz J., Clark P.I., Smith D.B., Donnelly R.J., Fayers P.M., Weeden S., et al. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002, 359:1727-1733.
3. Quint L.E., Hepburn L.M., Francis I.R., Whyte R.I., Orringer M.B. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995, 76:1120-1125.
4. Yamamoto T., Tachibana M., Kinugasa S., Yoshimura H., Nagasue N. Esophagectomy and hepatic arterial chemotherapy following hepatic resection for esophageal cancer with liver metastasis. J Gastroenterol 2001, 36:560-563.
5. Hanazaki K., Kuroda T., Wakabayashi M., Sodeyama H., Yokoyama S., Kusama J. Hepatic metastasis from esophageal cancer treated by surgical resection and hepatic arterial infusion chemotherapy. Hepatogastroenterology 1998, 45:201-205.
6. Kato H., Tachimori Y., Watanabe H., Iizuka T. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 1993, 53:220-223.
7. Shimada H., Kitabayashi H., Nabeya Y., Okazumi S., Matsubara H., Funami Y., et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003, 133:24-31.
8. Liu J.F., Wang Q.Z., Hou J. Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China. Br J Surg 2004, 91:90-98.
9. Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 2008, 16:447-451.
10. Kim S.T., Park K.H., Oh S.C., Seo J.H., Shin S.W., Kim J.S., et al. Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy. Oncology 2010, 79:363-369.
11. Sanchez-Munoz A., Perez-Ruiz E., Saez M.I., Trigo J.M., Galindo M.M., Manzaneque L., et al. Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status. Clin Transl Oncol 2011, 13:426-429.
12. Teo P.M., Kwan W.H., Lee W.Y., Leung S.F., Johnson P.J. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996, 77:2423-2431.
13. Stahl M., Budach W., Meyer H.J., Cervantes A. Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl 5):v46-v49. Group EGW.
14. Tanaka T., Fujita H., Matono S., Nagano T., Nishimura K., Murata K., et al. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org). Dis Esophagus 2010, 23:646-651.
15. Iwase H., Shimada M., Nakamura M., Nakarai K., Iyo T., Kaida S., et al. Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy. Int J Clin Oncol 2003, 8:305-311.
16. Kosugi S.I., Kanda T., Nishimaki T., Nakagawa S., Yajima K., Ohashi M., et al. Successful treatment for esophageal carcinoma with lung metastasis by induction chemotherapy followed by salvage esophagectomy: report of a case. World J Gastroenterol 2006, 12:4101-4103.
17. Nakada T., Nagayama K., Hiramoto J., Tsuruta Y., Murakami S., Sakabe S. Complete regression of esophageal cancer with concomitant liver metastasis achieved by concurrent chemoradiation therapy. Int J Clin Oncol 2002, 7:192-196.